Seprilose
Alternative Names: GW 80126Latest Information Update: 22 Aug 2007
At a glance
- Originator Boston Life Sciences
- Developer Boston Life Sciences; Kissei Pharmaceutical
- Class Anti-inflammatories; Antirheumatics; Carbohydrates
- Mechanism of Action Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders
Most Recent Events
- 22 Aug 2007 Discontinued - Preclinical for Rheumatic disorders in Japan (unspecified route)